Robert Ang

Company: Vor Biopharma

Job title: CEO

Seminars:

Allogeneic Genome-Engineered HSCT Enabling Post-Transplant Targeted Therapies 3:30 pm

Concept of creating treatment-resistant stem cell transplants via gene deletion of cell surface targets Implementing next-generation allogeneic healthy donor material supply chain to GMP engineered HSC transplants Coupling genome-engineered HSCT with CAR-T and beyondRead more

day: Day Two